EXCLUSIVE: AVEO CEO Explains How New Partnership Will Address $500 Million Opportunity Overseas

By: via Benzinga
• AVEO Pharmaceuticals, Inc. (NASDAQ: AVEO) has announced a partnership with EUSA Pharma granting EUSA exclusive European rights ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.